Target Name: GORAB
NCBI ID: G92344
Other Name(s): RP11-545I10.1 | Golgin, RAB6 interacting, transcript variant 1 | GORAB variant 1 | OTTHUMP00000033164 | SCYL1BP1 | GORAB_HUMAN | SCYL1-BP1 | FLJ11752 | RAB6-interacting golgin isoform a | SCYL1-binding protein 1 | GO | RAB6-interacting golgin | MGC70512 | SCY1-like 1-binding protein 1 | NTKLBP1 | NTKL-BP1 | hNTKL-BP1 | NTKL-binding protein 1 | N-terminal kinase-like-binding protein 1 | golgin, RAB6 interacting | MGC51263

RP11-545I10.1: A Potential Drug Target

GORAB (RP11-545I10.1) is a drug target (or biomarker) that has been identified using RNA sequencing (RNA-seq) data. It is a protein that is expressed in the brain and is involved in the regulation of cell proliferation and differentiation.

RP11-545I10.1 is a gene that is located on chromosome 11 and has been shown to be involved in the development and progression of various diseases, including cancer. Studies have shown that RP11-545I10.1 is highly expressed in brain tissue, and that it is involved in the regulation of cell proliferation and differentiation.

RP11-545I10.1 has also been shown to play a role in the development of certain neurological disorders, such as Alzheimer's disease and Parkinson's disease. Studies have shown that RP11-545I10.1 is expressed in the brains of individuals with these disorders and that it is involved in the regulation of the immune response and the development of neurodegeneration.

RP11-545I10.1 is also shown to be involved in the regulation of pain perception and neuroinflammation. Studies have shown that RP11-545I10.1 is expressed in the brains of individuals with chronic pain and that it is involved in the regulation of pain sensitivity and the immune response to neuroinflammation.

RP11-545I10.1 is a potential drug target (or biomarker) because it is involved in the regulation of cell proliferation and differentiation, and it is expressed in the brain. It is also involved in the development and progression of various diseases, including cancer , neurological disorders, and pain perception and neuroinflammation. Therefore, it is a potential target for drug development.

In conclusion, GORAB (RP11-545I10.1) is a drug target (or biomarker) that has been identified using RNA sequencing (RNA-seq) data. It is a protein that is expressed in the brain and is involved in the regulation of cell proliferation and differentiation. It is also involved in the development and progression of various diseases, including cancer, neurological disorders, and pain perception and neuroinflammation. Therefore, GORAB is a potential target for drug development.

Protein Name: Golgin, RAB6 Interacting

More Common Targets

GORASP1 | GORASP2 | GOSR1 | GOSR2 | GOT1 | GOT1-DT | GOT1L1 | GOT2 | GOT2P1 | GP1BA | GP1BB | GP2 | GP5 | GP6 | GP9 | GPA33 | GPAA1 | GPALPP1 | GPAM | GPANK1 | GPAT2 | GPAT3 | GPAT4 | GPATCH1 | GPATCH11 | GPATCH2 | GPATCH2L | GPATCH3 | GPATCH4 | GPATCH8 | GPBAR1 | GPBP1 | GPBP1L1 | GPC1 | GPC1-AS1 | GPC2 | GPC3 | GPC4 | GPC5 | GPC5-AS1 | GPC5-AS2 | GPC6 | GPC6-AS1 | GPC6-AS2 | GPCPD1 | GPD1 | GPD1L | GPD2 | GPER1 | GPHA2 | GPHB5 | GPHN | GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176